<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:06:09Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5601231" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5601231</identifier><datestamp>2017-10-03</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Angew Chem Int Ed Engl</journal-id>
      <journal-id journal-id-type="iso-abbrev">Angew. Chem. Int. Ed. Engl</journal-id>
      <journal-id journal-id-type="doi">10.1002/(ISSN)1521-3773</journal-id>
      <journal-id journal-id-type="publisher-id">ANIE</journal-id>
      <journal-title-group>
        <journal-title>Angewandte Chemie (International Ed. in English)</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1433-7851</issn>
      <issn pub-type="epub">1521-3773</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5601231</article-id>
      <article-id pub-id-type="pmcid">PMC5601231</article-id>
      <article-id pub-id-type="pmc-uid">5601231</article-id>
      <article-id pub-id-type="pmid">28661582</article-id>
      <article-id pub-id-type="doi">10.1002/anie.201704616</article-id>
      <article-id pub-id-type="publisher-id">ANIE201704616</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Communication</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Communications</subject>
          <subj-group subj-group-type="heading">
            <subject>Enzyme Structure and Function | Very Important Paper</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structure of Human Tyrosinase Related Proteinâ1 Reveals a Binuclear Zinc Active Site Important for Melanogenesis</article-title>
      </title-group>
      <contrib-group>
        <contrib id="anie201704616-cr-0001" contrib-type="author">
          <name>
            <surname>Lai</surname>
            <given-names>Xuelei</given-names>
            <prefix>Dr.</prefix>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4989-2444</contrib-id>
          <xref ref-type="aff" rid="anie201704616-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="anie201704616-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="anie201704616-cr-0002" contrib-type="author">
          <name>
            <surname>Wichers</surname>
            <given-names>Harry J.</given-names>
            <prefix>Prof.âDr.</prefix>
          </name>
          <xref ref-type="aff" rid="anie201704616-aff-0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="anie201704616-cr-0003" contrib-type="author" corresp="yes">
          <name>
            <surname>SolerâLopez</surname>
            <given-names>Montserrat</given-names>
            <prefix>Dr.</prefix>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5924-4734</contrib-id>
          <address>
            <email>montserrat.soler-lopez@esrf.fr</email>
          </address>
          <xref ref-type="aff" rid="anie201704616-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="anie201704616-cr-0004" contrib-type="author" corresp="yes">
          <name>
            <surname>Dijkstra</surname>
            <given-names>Bauke W.</given-names>
            <prefix>Prof.âDr.</prefix>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9731-6586</contrib-id>
          <address>
            <email>b.w.dijkstra@rug.nl</email>
          </address>
          <xref ref-type="aff" rid="anie201704616-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="anie201704616-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Laboratory of Biophysical Chemistry</named-content>
<institution>University of Groningen</institution>
<named-content content-type="street">Nijenborgh 7</named-content>
<named-content content-type="post-code">9747 AG</named-content>
<named-content content-type="city">Groningen</named-content>
<country country="NL">The Netherlands</country>
</aff>
      <aff id="anie201704616-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Structural Biology Group</named-content>
<institution>European Synchrotron Radiation Facility</institution>
<named-content content-type="street">71 Avenue des Martyrs</named-content>
<named-content content-type="post-code">38000</named-content>
<named-content content-type="city">Grenoble</named-content>
<country country="FR">France</country>
</aff>
      <aff id="anie201704616-aff-0003">
<label><sup>3</sup></label>
<institution>Wageningen Food &amp; Biobased Research</institution>
<named-content content-type="street">Bornse Weilanden 9</named-content>
<named-content content-type="post-code">6708 WG</named-content>
<named-content content-type="city">Wageningen</named-content>
<country country="NL">The Netherlands</country>
</aff>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>7</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>07</day>
        <month>8</month>
        <year>2017</year>
      </pub-date>
      <volume>56</volume>
      <issue>33</issue>
      <issue-id pub-id-type="doi">10.1002/anie.v56.33</issue-id>
      <fpage>9812</fpage>
      <lpage>9815</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>5</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 Wiley&#x02010;VCH Verlag GmbH & Co. KGaA, Weinheim <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2017 The Authors. Published by Wiley-VCH Verlag GmbH &amp; Co. KGaA.</copyright-statement>
        <license license-type="creativeCommonsBy-nc">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons AttributionâNonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:ANIE-56-9812.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>Tyrosinaseârelated proteinâ1 (TYRP1) is one of three tyrosinaseâlike glycoenzymes in human melanocytes that are key to the production of melanin, the compound responsible for the pigmentation of skin, eye, and hair. Difficulties with producing these enzymes in pure form have hampered the understanding of their activity and the effect of mutations that cause albinism and pigmentation disorders. Herein we show that the typical tyrosinaseâlike subdomain of TYRP1 contains two zinc ions in the active site instead of copper ions as found in tyrosinases, which explains why TYRP1 does not exhibit tyrosinase redox activity. In addition, the structures reveal for the first time that the Cysârich subdomain, which is unique to vertebrate melanogenic proteins, has an epidermal growth factorâlike fold and is tightly associated with the tyrosinase subdomain. Our structures suggest that most albinismârelated mutations of TYRP1 affect its stability or activity.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="anie201704616-kwd-0001">albinism</kwd>
        <kwd id="anie201704616-kwd-0002">human tyrosinase</kwd>
        <kwd id="anie201704616-kwd-0003">melanogenesis</kwd>
        <kwd id="anie201704616-kwd-0004">structure elucidation</kwd>
        <kwd id="anie201704616-kwd-0005">zincâcopper enzymes</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>European Synchrotron Radiation Facility</funding-source>
        </award-group>
        <award-group>
          <funding-source>University of Groningen (GBB)</funding-source>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="6"/>
        <table-count count="0"/>
        <ref-count count="18"/>
        <page-count count="4"/>
        <word-count count="0"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>anie201704616</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>August 7, 2017</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.1.9 mode:remove_FC converted:18.09.2017</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <p content-type="self-citation">
<mixed-citation publication-type="self-citation" id="anie201704616-self">X. Lai, H. J. Wichers, M. Soler-Lopez, B. W. Dijkstra, <italic>Angew. Chem. Int. Ed.</italic>
<bold>2017</bold>, <italic>56</italic>, 9812.</mixed-citation>
</p>
    </notes>
  </front>
  <body>
    <p>In humans, three enzymes are involved in the biosynthesis of melanin (FigureâS1 in the Supporting Information), the primary determinant of the color of the skin, hair and iris of the eye.<xref rid="anie201704616-bib-0001" ref-type="ref">1</xref> Tyrosinase (TYR) is the critical and rateâlimiting enzyme; it catalyzes the hydroxylation and subsequent oxidation of tyrosine. Tyrosinaseârelated proteinâ2 (TYRP2) is a tautomerase,<xref rid="anie201704616-bib-0002" ref-type="ref">2</xref> and tyrosinaseârelated proteinâ1 (TYRP1) has been suggested to catalyze the oxidation of 5,6âdihydroxyindoleâ2âcarboxylic acid (DHICA) in mice,<xref rid="anie201704616-bib-0003" ref-type="ref">3</xref> although this activity has been challenged in humans.<xref rid="anie201704616-bib-0004" ref-type="ref">4</xref> All three enzymes are metalâcontaining glycoproteins localized in melanosomes where melanin synthesis takes place. They share approximately 40â% amino acid sequence identity and contain four conserved regions: an Nâterminal signal peptide, an intramelanosomal domain, a single transmembrane Î±âhelix, and a small, flexible Câterminal cytoplasmic domain (Figureâ<xref rid="anie201704616-fig-0001" ref-type="fig">1</xref>âA). The intramelanosomal domain contains a Cysârich subdomain, unique to mammalian tyrosinases, and a tyrosinaseâlike subdomain with a binuclear metalâionâbinding sequence motif. Mutations in the <italic>TYR</italic> or <italic>TYRP1</italic> genes result in oculocutaneous albinism (OCA), a group of autosomal recessive disorders characterized by reduced production of melanin in skin, hair, and eyes, with OCA3 resulting from <italic>TYRP1</italic> mutations. In addition, <italic>TYR</italic> and <italic>TYRP1</italic> variants are significantly associated with risk of melanoma,<xref rid="anie201704616-bib-0005" ref-type="ref">5</xref> a malignant tumor of melanocytes that, because of its aggressive nature, causes the majority of deaths related to skin cancer.<xref rid="anie201704616-bib-0006" ref-type="ref">6</xref> Inhibition of melanogenesis may be an efficient therapeutic strategy, as evidenced by phase 1 clinical trials with a recombinant human monoclonal antibody against TYRP1.<xref rid="anie201704616-bib-0007" ref-type="ref">7</xref>
</p>
    <fig fig-type="Figure" xml:lang="en" id="anie201704616-fig-0001" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>A)âTYRP1 contains 4âconserved regions: the signal peptide (yellow, residues 1â24), the intramelanosomal (or luminal) domain (25â477, subdivided into the Cysârichâ(green, 25â126) and the tyrosinaseâlikeâ(blue, 127â477) subdomains), the transmembrane Î±âhelixâ(gray, 478â501), and the cytoplasmic domainâ(orange, 502â537). B)âOverall structure of the intramelanosomal domain, same coloring as inâ(A). The six Asn sites with Nâlinked sugars (96, 104, 181, 304, 350, and 385) are shown as sticks and the disulfide bonds are shown in orange. The two metal ions (A and B) are shown as pink spheres.</p>
      </caption>
      <graphic id="nlm-graphic-3" xlink:href="ANIE-56-9812-g001"/>
    </fig>
    <p>Although we recently succeeded in the recombinant production of intramelanosomal human TYR,<xref rid="anie201704616-bib-0008" ref-type="ref">8</xref> its crystallization was not suitable for structure determination. Herein we report the crystal structure of intramelanosomal human TYRP1 and in complex with tyrosinase substrates and inhibitors, which reveal for the first time the structure of a mammalian tyrosinase family member. We show that the active site contains two zinc ions, rather than copper ions as in tyrosinases, which makes it unlikely that human TYRP1 is a redox enzyme, as had been assumed for the last three decades.</p>
    <p>The 2.35âÃ resolution crystal structure of intramelanosomal TYRP1 (Figureâ<xref rid="anie201704616-fig-0001" ref-type="fig">1</xref>âB, TableâS1) reveals a compact globular shape, with tight interactions between the Cysârich and tyrosinase subdomains. Furthermore, all six Asn Nâglycosylation motifs bear glycans (96, 104, 181, 304, 350, and 385) (Figureâ<xref rid="anie201704616-fig-0001" ref-type="fig">1</xref>âB and FigureâS2). The tyrosinaseâlike subdomain (residues 127â477) has the typical tyrosinase fold, consisting of a fourâhelix bundle (Î±3, Î±4, Î±8, and Î±9) connected by long loops. It is most similar to the bacterial <italic>Bacillus megaterium</italic> tyrosinase (BmTYR, PDB entryâ3NM8),<xref rid="anie201704616-bib-0009" ref-type="ref">9</xref> with 32â% sequence identity and an rmsd of 1.6âÃ for 263 aligned amino acids. The most conspicuous differences are three long insertions that cluster together at one side of the tyrosinaseâlike subdomain (Figureâ<xref rid="anie201704616-fig-0002" ref-type="fig">2</xref>; residues 155â182, 199â204, and 291â300). These loops extend away from the entrance to the active site, and interact with the Cysârich subdomain. Two disulfide bonds (C258âC261 and C290âC303) stabilize the tyrosinase subdomain (disulfide bondsâ6 andâ7 in FigureâS2).
</p>
    <fig fig-type="Figure" xml:lang="en" id="anie201704616-fig-0002" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Superposition of the TYRP1 and <italic>Bacillus megaterium</italic> TYR crystal structures. BmTYR is represented as a gray structure and light gray surface (PDB 3NM8).<xref rid="anie201704616-bib-0009" ref-type="ref">9</xref> The tyrosinase subdomain of TYRP1 is shown in blue and the Cysârich subdomain in light green. Loops with different lengths between TYRP1 and BmTYR are indicated. Disulfide bonds are shown in orange and the two metal ions (A and B) in pink. The disulfide residues stabilizing the TYRP1 tyrosinase subdomain are indicated as orange sticks.</p>
      </caption>
      <graphic id="nlm-graphic-5" xlink:href="ANIE-56-9812-g002"/>
    </fig>
    <p>The core of the Cysârich subdomain (residues 25â126) has an epidermal growth factor (EGF)âlike fold (SCOP family g.3.11.1) similar to the structure of the human epidermal growth factor (FigureâS3), formed by two pairs of short antiparallel Î²âstrands (Î²1/Î²2 (residues 62â66/98â102) and Î²4/Î²5 (116â118/124â126; Figureâ<xref rid="anie201704616-fig-0001" ref-type="fig">1</xref>âB) from which long loops emerge. They are stabilized by disulfide bonds that follow the [C<sub>1</sub>âC<sub>3</sub>, C<sub>2</sub>âC<sub>4</sub>, C<sub>5</sub>âC<sub>6</sub>] signature pattern of EGFâlike structures,<xref rid="anie201704616-bib-0010" ref-type="ref">10</xref> corresponding to cysteine residues 42â65, 56â99, 101â110. The subdomain associates with the tyrosinaseâlike subdomain via its Nâterminus and the long 67â97 loop extending from the core. The subdomain is located far from the active site, at the opposite side of the molecule (Figureâ<xref rid="anie201704616-fig-0001" ref-type="fig">1</xref>âB), making a direct effect on the activity of TYRP1 unlikely. Although the Cysârich subdomain has been suggested to be involved in oligomerization,<xref rid="anie201704616-bib-0011" ref-type="ref">11</xref> we did not find evidence for this, since purified intramelanosomal domains of both TYRP1 and TYR elute as monomers on sizeâexclusion chromatography (FigureâS4A), and coâelution of TYRP1 and TYR did neither produce a heterodimer (FigureâS4B).</p>
    <p>TYRP1 has a binuclear metalâbinding site that resembles the classical typeâ3 binuclear copperâbinding site of hemocyanins and tyrosinases (Figureâ<xref rid="anie201704616-fig-0003" ref-type="fig">3</xref>), but the nature of the bound metal ions has been unclear.<xref rid="anie201704616-bib-0012" ref-type="ref">12</xref> Using Xâray fluorescence, we found that TYRP1 crystals contained zinc, while TYR crystals contained copper (FigureâS5). The presence of zinc in TYRP1 was further confirmed by Xâray anomalous dispersion data collected at the zinc absorption edge, which showed that the TYRP1 zinc ions occupy the positions of copper ions in tyrosinases (FigureâS6 and TableâS1). Both zinc ions in the active site are bound with a nearly planar trigonal geometry, slightly out of the plane defined by the NÏµ2 atoms of their ligands. The distance between the ZnA and ZnB ions (Figureâ<xref rid="anie201704616-fig-0003" ref-type="fig">3</xref>) is 3.5Â±0.1âÃ. A bridging water molecule or hydroxide ion can be modeled with a distance of 2.1Â±0.1âÃ to the two zinc ions (Figureâ<xref rid="anie201704616-fig-0003" ref-type="fig">3</xref>âA and FigureâS7A). Although we carried out repeated productions of TYRP1 and TYR samples under identical cell culture conditions and in the absence of external sources of zinc or copper ions in the media, the two proteins consistently contain different ions, unambiguously proving that TYR is a copperâbinding enzyme while TYRP1 is a zincâbinding enzyme.
</p>
    <fig fig-type="Figure" xml:lang="en" id="anie201704616-fig-0003" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Metalâion binding in the TYRP1 active site. A)âCloseâup of the TYRP1 active site. Zn ions are shown as pink spheres with the bridging water molecule in red (w<sub>zn</sub>). Metal coordination distances are labeled. B)âSuperposition of TYRP1 and BmTYR active sites. The Cu ions present in BmTYR are shown in orange, and the bridging water molecule (w<sub>cu</sub>) in red. Metalâcoordination distances are displayed in dark gray and labeled. The location of metalâB is better conserved than metalâA, in agreement with previous observations<xref rid="anie201704616-bib-0014" ref-type="ref">14</xref> (see Figureâ<xref rid="anie201704616-fig-0005" ref-type="fig">5</xref>). Numbering of His residues is indicated for TYRP1â(blue) and BmTYRâ(gray).</p>
      </caption>
      <graphic id="nlm-graphic-7" xlink:href="ANIE-56-9812-g003"/>
    </fig>
    <p>Generally, it has been assumed that TYRP1 is a DHICA oxidase.<xref rid="anie201704616-bib-0013" ref-type="ref">13</xref> Yet, human TYRP1 was found to be devoid of DHICA activity,<xref rid="anie201704616-bib-0004" ref-type="ref">4</xref> and also in our studies the intramelanosomal domain of TYRP1 did not display any DHICA activity nor tyrosine hydroxylase or <sc>l</sc>âDOPA oxidase activity (Figureâ<xref rid="anie201704616-fig-0004" ref-type="fig">4</xref>). The nature of the metal ions in the active site is partly responsible for these differences in activity, since exchanging the Zn<sup>2+</sup>/Cu<sup>2+</sup> cofactors of TYRP1/TYR for Cu<sup>2+</sup>/Zn<sup>2+</sup> conferred TYRâlevel DHICA oxidase activity to TYRP1, but no significant <sc>l</sc>âDOPA oxidase and tyrosine hydroxylase activities. Only a prolonged (up to 160âmin) onâplate tyrosinase activity assay with TYRP1âCu did show some low tyrosinase activity (Figureâ<xref rid="anie201704616-fig-0004" ref-type="fig">4</xref>âD). In contrast, TYRâZn had almost no activity, with the residual activity likely resulting from incomplete removal of the copper ions. Amino acid substitutions in the active site affect the activity profile only to a minor extent. A triple mutant, which had the three nonâidentical residues replaced by the corresponding ones of TYR (Y362F/R374S/T391V; TYRP1â3M), had similar activities as native TYRP1, both in the Znâ and Cuâsubstituted forms. Thus, our results suggest that it is unlikely that TYRP1 is a redox enzyme.
</p>
    <fig fig-type="Figure" xml:lang="en" id="anie201704616-fig-0004" orientation="portrait" position="float">
      <label>Figure 4</label>
      <caption>
        <p>A)âC)âActivity assays of TYR,<xref rid="anie201704616-bib-0008" ref-type="ref">8</xref> TYRP1, and their corresponding apoâproteins recharged with Zn or Cu ions. TYRP1â3M is the triple Y362F/R374S/T391V mutant. For details see TableâS2. D)âColorimetric activity assay. Enzymes added are indicated on the right. The pink pigment is the tyrosinase activity product dopaquinone in complex with MBTH, which appears after ca. 1âmin for TYR, ca. 20âmin for TYRP1â3MâCu, and ca. 40âmin for TYRP1âCu, and accumulates over time. Wellâ1 (W1) is a blank control. W2*, W4*, and W6* contain tyrosinase inhibitors as negative controls. W3 and W5 show no pigment, indicating that TYRP1 and TYRP1â3M have no tyrosinase activity. W6 is darker than W4 at the same time point, indicating that TYRP1â3MâCu presents higher tyrosinase activity than TYRP1âCu.</p>
      </caption>
      <graphic id="nlm-graphic-9" xlink:href="ANIE-56-9812-g004"/>
    </fig>
    <p>TYRP1 binds typical tyrosinase substrates and inhibitors (Figureâ<xref rid="anie201704616-fig-0005" ref-type="fig">5</xref>, TableâS1). Importantly, <sc>l</sc>âtyrosine and the <sc>l</sc>âDOPA analogue <sc>l</sc>âmimosine do not directly interact with the zinc ions, but their aromatic hydroxy and ketoâgroups are hydrogenâbonded to the water molecule bridging the two zinc ions (FigureâS7B). Additional interactions include offset aromatic stacking interactions with His381, and hydrogen bonding interactions of their carboxylate group with Arg374 and Ser394 (Figureâ<xref rid="anie201704616-fig-0005" ref-type="fig">5</xref>âA,B). The electron density of <sc>l</sc>â mimosine is better defined than that of <sc>l</sc>âtyrosine, suggesting that the interactions of the Ïµâhydroxy group increase the binding affinity of mimosine. In contrast, the metal chelator tropolone does have direct interactions with the ZnA ion (Figureâ<xref rid="anie201704616-fig-0005" ref-type="fig">5</xref>âC). Interestingly, ZnA has shifted by 1.5âÃ towards tropolone compared to native TYRP1, indicating that the metal ion site is somewhat flexible. The skinâwhitening agent kojic acid binds with its ring hydroxy and keto groups at approximately 3âÃ from the zinc ions, which is too far for good coordination (Figureâ<xref rid="anie201704616-fig-0005" ref-type="fig">5</xref>âD). Interestingly, the amino acid differences between the active sites of TYRP1 and TYR do not affect the binding modes of these compounds, as shown by crystal structures of the TYRP1â3M mutant (see above) with/without bound <sc>l</sc>âmimosine, tropolone and kojic acid (FigureâS8, TableâS1). Despite removal of hydrogenâbonding interactions by the mutations, the compounds bind in a similar conformation as in native TYRP1. Apparently, the stacking interaction with His381 and the hydrogen bonds of aromatic ketoâ and hydroxy groups are sufficient for binding. This finding implies that recognition of the substrate's carboxylate group is not essential and that, in addition to DHICA, TYRP1 may also be active on 5,6âdihydroxyindole (DHI) (FigureâS1).
</p>
    <fig fig-type="Figure" xml:lang="en" id="anie201704616-fig-0005" orientation="portrait" position="float">
      <label>Figure 5</label>
      <caption>
        <p>Binding of tyrosinase substrates and inhibitors. <sc>l</sc>âtyrosineâ(A) and mimosineâ(B) bind with their carboxylate groups to R374. Tropoloneâ(C) and kojic acidâ(D) bind in the same position. Each compound is shown with its 2â<italic>F</italic>
<sub>o</sub>â<italic>F</italic>
<sub>c</sub> electron density mapâ(gray wire) contoured at 0.9âÏ. Zinc ions are shown as pink spheres and water molecules as red spheres. Contacts of the compounds with TYRP1 residues and the Zn ions are shown as dashed lines.</p>
      </caption>
      <graphic id="nlm-graphic-11" xlink:href="ANIE-56-9812-g005"/>
    </fig>
    <p>Fifteen OCA3ârelated mutations in the <italic>TYRP1</italic> gene have so far been found, including 8 point mutations (C30R, R93C, H215Y, T253M, C290Y, R356Q, M452V, and P513R; FigureâS9).<xref rid="anie201704616-bib-0015" ref-type="ref">15</xref> Most of these residues contribute to the stability. The C30âC41 disulfide bond attaches helixâÎ±1 to the core of the Cysârich subdomain, the C290âC303 disulfide bond stabilizes the 290â303 loop, and R356 is part of an extensive buried hydrogenâbonding network. H215 is a ZnA ligand, and replacement by Tyr may reduce the enzyme's zincâbinding affinity and activity. T253M and M452V are missense mutations found in Caucasian patients that are yet to be confirmed as pathological mutations.<xref rid="anie201704616-bib-0016" ref-type="ref">16</xref>
</p>
    <p>T253 is located on a surface loop, far away from the active site, and the introduction of a large apolar methionine at this position may lead to local unfolding and/or aggregation. M452 is located in the interface between the Cysârich and tyrosinaseâlike subdomains. Replacement by Val may reduce part of its hydrophobic interactions, which may have a (probably minor) effect on the stability of the enzyme. The R93C substitution causes blond hair in normally blackâhaired Melanesian individuals.<xref rid="anie201704616-bib-0017" ref-type="ref">17</xref> R93 is near a cluster of four disulfide bonds in the Cysârich subdomain (FigureâS9), and replacement by a cysteine could interfere with correct disulfide bond formation or even correct folding. Finally, the P513R mutation is in the cytosolic tail domain, which is critical for targeting melanogenic proteins to the melanosomal membrane.<xref rid="anie201704616-bib-0018" ref-type="ref">18</xref> The P513R replacement may thus interfere with translocation of TYRP1 to the melanosomal membrane.</p>
    <p>In summary, the crystal structure of intramelanosomal human tyrosinaseârelated proteinâ1 (TYRP1) has revealed for the first time the structure of a mammalian tyrosinase family member. We provide compelling evidence for the presence of two zinc ions in the active site, which makes it unlikely that human TYRP1 is a redox enzyme, in contrast to what has been assumed for the last three decades. Which reaction TYRP1 does catalyze is unclear at this moment, although the effect of mutations in the <italic>TYRP1</italic> gene suggest the utmost importance of TYRP1 for the biosynthesis of melanin.</p>
    <sec disp-level="2" id="anie201704616-sec-0003" sec-type="conflict-of-interest">
      <title>Conflict of interest</title>
      <p>The authors declare no conflict of interest.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data">
        <p>As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be reâorganized for online delivery, but are not copyâedited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.</p>
      </supplementary-material>
      <supplementary-material content-type="local-data">
        <caption>
          <p>Supplementary</p>
        </caption>
        <media xlink:href="ANIE-56-9812-s001.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="anie201704616-sec-0002">
      <title>Acknowledgements</title>
      <p>We thank ESRF beamline scientists D. deâSanctis (ID29), A. Popov (ID23â1), and M. Bowler (MASSIFâ1) for assistance during data collection, and F. Garzoni (Eukaryotic Expression Platform at EMBL Grenoble) for help with protein expression in insect cells. The Structural Biology Group at the ESRF and the Groningen Biomolecular Sciences and Biotechnology Institute (University of Groningen) supported this work.</p>
    </ack>
    <ref-list>
      <ref id="anie201704616-bib-0001">
        <label>1</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0001">
<string-name>
<given-names>J. L.</given-names>
<surname>Rees</surname>
</string-name>, <source>Annu. Rev. Genet.</source>
<year>2003</year>, <volume>37</volume>, <fpage>67</fpage>â<lpage>90</lpage>.<pub-id pub-id-type="pmid">14616056</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0002">
        <label>2</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0002">
<string-name>
<given-names>Y.</given-names>
<surname>Yamaguchi</surname>
</string-name>, <string-name>
<given-names>V. J.</given-names>
<surname>Hearing</surname>
</string-name>, <source>Cold Spring Harbor Perspect. Med.</source>
<year>2014</year>, <volume>4</volume>, a<fpage>017046</fpage>.</mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0003">
        <label>3</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0003">
<string-name>
<given-names>T.</given-names>
<surname>Kobayashi</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Urabe</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Winder</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>JimÃ©nez-Cervantes</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Imokawa</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Brewington</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Solano</surname>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>GarcÃ­a-BorrÃ³n</surname>
</string-name>, <string-name>
<given-names>V. J.</given-names>
<surname>Hearing</surname>
</string-name>, <source>EMBO J.</source>
<year>1994</year>, <volume>13</volume>, <fpage>5818</fpage>â<lpage>5825</lpage>.<pub-id pub-id-type="pmid">7813420</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0004">
        <label>4</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0004">
<string-name>
<given-names>R. E.</given-names>
<surname>Boissy</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Sakai</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Zhao</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Kobayashi</surname>
</string-name>, <string-name>
<given-names>V. J.</given-names>
<surname>Hearing</surname>
</string-name>, <source>Exp. Dermatol.</source>
<year>1998</year>, <volume>7</volume>, <fpage>198</fpage>â<lpage>204</lpage>.<pub-id pub-id-type="pmid">9758418</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0005">
        <label>5</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0005">
<string-name>
<given-names>G.</given-names>
<surname>Ghanem</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Fabrice</surname>
</string-name>, <source>Mol. Oncol.</source>
<year>2011</year>, <volume>5</volume>, <fpage>150</fpage>â<lpage>155</lpage>.<pub-id pub-id-type="pmid">21324755</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0006">
        <label>6</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0006">
<string-name>
<given-names>R. L.</given-names>
<surname>Siegel</surname>
</string-name>, <string-name>
<given-names>K. D.</given-names>
<surname>Miller</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Jemal</surname>
</string-name>, <source>Ca-Cancer J. Clin.</source>
<year>2016</year>, <volume>66</volume>, <fpage>7</fpage>â<lpage>30</lpage>.<pub-id pub-id-type="pmid">26742998</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0007">
        <label>7</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0007">
<string-name>
<given-names>D. N.</given-names>
<surname>Khalil</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Postow</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Ibrahim</surname>
</string-name>, <string-name>
<given-names>D. L.</given-names>
<surname>Ludwig</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Cosaert</surname>
</string-name>, <string-name>
<given-names>S. R. P.</given-names>
<surname>Kambhampati</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Tang</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Grebennik</surname>
</string-name>, <string-name>
<given-names>J. S. W.</given-names>
<surname>Kauh</surname>
</string-name>, <string-name>
<given-names>H.-J.</given-names>
<surname>Lenz</surname>
</string-name>, etâal., <source>Clin. Cancer Res.</source>
<year>2016</year>, <volume>22</volume>, <fpage>5204</fpage>â<lpage>5210</lpage>.<pub-id pub-id-type="pmid">27797971</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0008">
        <label>8</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0008">
<string-name>
<given-names>X.</given-names>
<surname>Lai</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Soler-Lopez</surname>
</string-name>, <string-name>
<given-names>H. J.</given-names>
<surname>Wichers</surname>
</string-name>, <string-name>
<given-names>B. W.</given-names>
<surname>Dijkstra</surname>
</string-name>, <source>PLoS One</source>
<year>2016</year>, <volume>11</volume>, e<fpage>0161697</fpage>.</mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0009">
        <label>9</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0009">
<string-name>
<given-names>M.</given-names>
<surname>Sendovski</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kanteev</surname>
</string-name>, <string-name>
<given-names>V. S.</given-names>
<surname>Ben-Yosef</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Adir</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Fishman</surname>
</string-name>, <source>J. Mol. Biol.</source>
<year>2011</year>, <volume>405</volume>, <fpage>227</fpage>â<lpage>237</lpage>.<pub-id pub-id-type="pmid">21040728</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0010">
        <label>10</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0010">
<string-name>
<given-names>H. S.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>J. J.</given-names>
<surname>Chai</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>B. R.</given-names>
<surname>Huang</surname>
</string-name>, <string-name>
<given-names>C. H.</given-names>
<surname>He</surname>
</string-name>, <string-name>
<given-names>R. C.</given-names>
<surname>Bi</surname>
</string-name>, <source>J. Biol. Chem.</source>
<year>2001</year>, <volume>276</volume>, <fpage>34913</fpage>â<lpage>34917</lpage>.<pub-id pub-id-type="pmid">11438527</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0011">
        <label>11</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0011">
<string-name>
<given-names>I. J.</given-names>
<surname>Jackson</surname>
</string-name>, <string-name>
<given-names>D. M.</given-names>
<surname>Chambers</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Tsukamoto</surname>
</string-name>, <string-name>
<given-names>N. G.</given-names>
<surname>Copeland</surname>
</string-name>, <string-name>
<given-names>D. J.</given-names>
<surname>Gilbert</surname>
</string-name>, <string-name>
<given-names>N. A.</given-names>
<surname>Jenkins</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Hearing</surname>
</string-name>, <source>EMBO J.</source>
<year>1992</year>, <volume>11</volume>, <fpage>527</fpage>â<lpage>535</lpage>.<pub-id pub-id-type="pmid">1537334</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0012">
        <label>12</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0012">
<string-name>
<given-names>M.</given-names>
<surname>Furumura</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Solano</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Matsunaga</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Sakai</surname>
</string-name>, <string-name>
<given-names>R. A.</given-names>
<surname>Spritz</surname>
</string-name>, <string-name>
<given-names>V. J.</given-names>
<surname>Hearing</surname>
</string-name>, <source>Biochem. Biophys. Res. Commun.</source>
<year>1998</year>, <volume>242</volume>, <fpage>579</fpage>â<lpage>585</lpage>.<pub-id pub-id-type="pmid">9464259</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0013">
        <label>13</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0013">
<string-name>
<given-names>R.</given-names>
<surname>Sarangarajan</surname>
</string-name>, <string-name>
<given-names>R. E.</given-names>
<surname>Boissy</surname>
</string-name>, <source>Pigment Cell Res.</source>
<year>2001</year>, <volume>14</volume>, <fpage>437</fpage>â<lpage>444</lpage>.<pub-id pub-id-type="pmid">11775055</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0014">
        <label>14</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0014">
<string-name>
<given-names>B.</given-names>
<surname>Deri</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kanteev</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Goldfeder</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Lecina</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Guallar</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Adir</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Fishman</surname>
</string-name>, <source>Sci. Rep.</source>
<year>2016</year>, <volume>6</volume>, <fpage>34993</fpage>.<pub-id pub-id-type="pmid">27725765</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0015">
        <label>15</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0015">
<string-name>
<given-names>P. D.</given-names>
<surname>Stenson</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Mort</surname>
</string-name>, <string-name>
<given-names>E. V.</given-names>
<surname>Ball</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Howells</surname>
</string-name>, <string-name>
<given-names>A. D.</given-names>
<surname>Phillips</surname>
</string-name>, <string-name>
<given-names>N. S.</given-names>
<surname>Thomas</surname>
</string-name>, <string-name>
<given-names>D. N.</given-names>
<surname>Cooper</surname>
</string-name>, <source>Genome Med.</source>
<year>2009</year>, <volume>1</volume>, <fpage>13</fpage>.<pub-id pub-id-type="pmid">19348700</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0016">
        <label>16</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0016">
<string-name>
<given-names>S. M.</given-names>
<surname>Hutton</surname>
</string-name>, <string-name>
<given-names>R. A.</given-names>
<surname>Spritz</surname>
</string-name>, <source>Invest. Ophthalmol. Visual Sci.</source>
<year>2008</year>, <volume>49</volume>, <fpage>868</fpage>â<lpage>872</lpage>.<pub-id pub-id-type="pmid">18326704</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0017">
        <label>17</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0017">
<string-name>
<given-names>E. E.</given-names>
<surname>Kenny</surname>
</string-name>, <string-name>
<given-names>N. J.</given-names>
<surname>Timpson</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Sikora</surname>
</string-name>, <string-name>
<given-names>M.-C.</given-names>
<surname>Yee</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Moreno-Estrada</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Eng</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Huntsman</surname>
</string-name>, <string-name>
<given-names>E. G.</given-names>
<surname>Burchard</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Stoneking</surname>
</string-name>, <string-name>
<given-names>C. D.</given-names>
<surname>Bustamante</surname>
</string-name>, etâal., <source>Science</source>
<year>2012</year>, <volume>336</volume>, <fpage>554</fpage>â<lpage>554</lpage>.<pub-id pub-id-type="pmid">22556244</pub-id></mixed-citation>
      </ref>
      <ref id="anie201704616-bib-0018">
        <label>18</label>
        <mixed-citation publication-type="journal" id="anie201704616-cit-0018">
<string-name>
<given-names>P. A.</given-names>
<surname>Calvo</surname>
</string-name>, <string-name>
<given-names>D. W.</given-names>
<surname>Frank</surname>
</string-name>, <string-name>
<given-names>B. M.</given-names>
<surname>Bieler</surname>
</string-name>, <string-name>
<given-names>J. F.</given-names>
<surname>Berson</surname>
</string-name>, <string-name>
<given-names>M. S.</given-names>
<surname>Marks</surname>
</string-name>, <source>J. Biol. Chem.</source>
<year>1999</year>, <volume>274</volume>, <fpage>12780</fpage>â<lpage>12789</lpage>.<pub-id pub-id-type="pmid">10212263</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>